QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 249 filers reported holding QIAGEN NV in Q3 2018. The put-call ratio across all filers is 4.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $220,000 | +3.8% | 4,171 | +3.0% | 0.02% | -4.5% |
| Q3 2020 | $212,000 | -17.8% | 4,051 | -34.7% | 0.02% | -4.3% |
| Q1 2020 | $258,000 | +22.3% | 6,202 | -0.8% | 0.02% | +130.0% |
| Q4 2019 | $211,000 | -15.6% | 6,249 | +1.2% | 0.01% | -16.7% |
| Q2 2019 | $250,000 | -4.2% | 6,177 | -3.9% | 0.01% | -7.7% |
| Q1 2019 | $261,000 | +19.7% | 6,427 | +1.8% | 0.01% | 0.0% |
| Q4 2018 | $218,000 | -33.5% | 6,314 | -27.0% | 0.01% | -13.3% |
| Q3 2018 | $328,000 | -5.7% | 8,649 | -10.2% | 0.02% | -11.8% |
| Q2 2018 | $348,000 | -14.5% | 9,628 | -23.6% | 0.02% | -10.5% |
| Q1 2018 | $407,000 | -19.7% | 12,602 | -23.1% | 0.02% | +11.8% |
| Q4 2017 | $507,000 | -4.3% | 16,378 | -2.6% | 0.02% | -5.6% |
| Q3 2017 | $530,000 | -5.9% | 16,817 | +0.1% | 0.02% | -5.3% |
| Q2 2017 | $563,000 | +15.1% | 16,804 | -0.5% | 0.02% | +18.8% |
| Q1 2017 | $489,000 | – | 16,895 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |